Skip to main content
. 2021 May 7;14(5):442. doi: 10.3390/ph14050442

Figure 51.

Figure 51

(a) Chemical structure of β-glucuronic linker and corresponding release mechanism. Drugs contains primary (doxorubicin) or secondary amine (MMAE, MMAF) (b) Chemical structure and release mechanism of DMED-containing β-Glucuronidase cleavable linker. Drug structures are omitted for clarity.